DarioHealth transforms chronic condition management by making it easier for people to care for their health with continuous and connected support. Our person-centric platform combines innovative technology and devices along with coaching and support across one experience for multiple chronic conditions. This approach empowers people to holistically adapt their lifestyles for sustainable behavior change, driving exceptional user satisfaction, retention, and results.
So much of the morbidity and mortality in the US and around the world is related to chronic disease. We need to be able to stem the tide and develop innovative approaches to improve overall health. Diabetes has long been the prototype disease for new care models and I look forward to sharing the important principles that can be translated to other chronic diseases during this interesting conference.
Chronic disease continues to challenge our healthcare system increasing disability and healthcare costs. This is exceedingly more challenging in the dually eligible health plan population who have divers needs and patterns. I am excited to have the opportunity to knowledge share with others and provide insights into my experience as a clinician and Chronic Disease Program Director on how we can begin to support chronic disease management and prevention.
Tackling the multi-faceted nature of living with multiple chronic conditions is what we strive for all day at Upward Health. Siloed one-size-fits-all methodologies aren’t cutting it anymore, and a new way forward is required. I look forward to sharing and learning from each other!
Care delivery is fragmented – organized around distinct specialties – driven by the realities of a fee-for-service financing system. Technology is fragmented – organized on proprietary platforms. The delivery system is fundamentally flawed in its ability to care for people in our communities with multiple chronic diseases. I’m looking forward to coming together to discuss how we can collectively optimize outcomes for chronic disease while reducing health disparities.
U.S. health care is waking up to the importance of the social determinants of health. To improve health outcomes, contain costs, and enhance patient trust in the health care system, it is imperative that we develop new, person-centered care models integrating social and clinical care.
Patient-centricity is at the forefront of the Future of Chronic Disease summit. Effective conversations around the future of chronic disease could not be had without considering the management of chronic disease from a patient’s perspective. This conference ensures this perspective is integrated into and valued in all key topics, to ensure the Future of Chronic Disease is bright for all.
With a focus on collaboration, this summit will bring together those in adjacent fields for the first time to overcome challenges in chronic disease. This event will harness the power of collaboration both on and off the stage, with ample opportunities to network with other senior-level experts as well as to be inspired by industry leaders in discussion-focused sessions.
This senior-level speaker faculty brings a wealth of experience from across chronic diseases. Be inspired by and learn amongst industry leaders from a variety of stakeholder groups, including experts from healthcare payers, healthcare providers, patient organizations, governmental bodies, pharmaceutical companies and academia. Take a look below to see our expert speaker faculty.
Robert A. Gabbay, MD, PhD, FACP, is the Chief Scientific and Medical Officer for the American Diabetes Association (ADA), the global authority on diabetes. Dr. Gabbay leads the ADA’s efforts to drive discovery within the world of diabetes research, care and prevention.
With over 35 years of clinical and research experience, and as a practicing endocrinologist, Dr. Gabbay has extensive experience in interventions targeting primary care and quality improvement. His research has been focused on innovative models of diabetes care to improve diabetes outcomes and the lives of people with diabetes.
Dr. Gabbay has received funding from the National Institute of Health Diabetes, Digestive and Kidneys Diseases (NIDDK), the Agency for Healthcare Research and Quality (AHRQ), and the Center for Medicare and Medicaid Innovation for his care transformation work. The reach of his work has been recognized through leadership roles in national and international activities including serving as a visiting professor, keynote speaker and on organizing committees for global meetings of the ADA, International Diabetes Federation, Endocrine Society, and the Diabetes Technology Society. Along with an extensive peer reviewed publication record, he has also appeared in popular press including the New York Times, CNN, Oprah, the Washington Post and NPR.
Previously, Dr. Gabbay served as the Chief Medical Officer and Senior Vice President at Joslin Diabetes Center, and Associate Professor at Harvard Medical School. At Joslin, he oversaw the clinical care for over 25,000 patients, as well as the education and care programs Joslin delivers nationally and internationally.
Dr. Gabbay obtained his B.Sc. Degree at McGill University and his Ph.D. in Biochemistry from the University of Wisconsin where he published on mechanisms of insulin signaling. He received his M.D. from the State University of New York at Brooklyn School of Medicine with a residency in Internal Medicine at New York Hospital-Cornell and a fellowship in Endocrinology, Diabetes and Metabolism at a joint Joslin-Beth Israel Deaconess-Brigham and Women’s Hospital program at Harvard University. Dr. Gabbay was also a visiting scientist at MIT and a Professor of Medicine at Pennsylvania State University College of Medicine.
Amal Agarwal, D.O., MBA, is the Vice President of Home Solutions at Humana overseeing disruptive care models to bring advanced care into the home. He is a board-certified emergency room physician on staff at the Robley Rex VA where he provides ER care for our vets. Prior to joining Humana Dr. Agarwal was a management consultant at Accenture and the Chief Medical Officer for Apervita. Dr. Agarwal’s mission is to improve access to personalized proactive care. Prior to co-creating the home team Dr. Agarwal oversaw the kidney strategy for Humana. He is a board observer for Monogram, a clinical advisor for Rubicon and BlocHealth. Outside of work, Dr. Agarwal enjoys time with his wife and their three young children.
Senior Executive Health Services Leader with 40 years of experience in nursing, 20+ in health care and health plan administration and new business development. Direct clinical experience in palliative care, hospice care, home care, pain management, and case management practice. Current nursing license in three states: Ohio, Florida, and Arizona and certified in case management. In-depth understanding of the challenges facing complex and underserved populations/Medicaid and Medicare recipients both from the direct clinical practice and payer side. Experience includes executive leadership of health plan clinical service areas including case management, disease management /population health, utilization management, quality management/improvement, and 24-hour nurse triage; as well as designing innovative programs to help better serve the needs of Medicaid / Medicare members while driving financial efficiency. Experience in clinical program design and implementation for new and existing public sector health plan programs. These programs include behavioral and physical health specialty integration and long-term services and supports. Prior experience includes senior-level positions on both the provider and payer side.
Tiffany Patrick, MPH, MBA is a 20+-year veteran of the biotech industry, is the Vice President of Global Patient Advocacy and Engagement (PAE) at Alnylam. Tiffany and her team at Alnylam work with close to 100 rare disease patient organizations around the world, and support integrating the patient perspective throughout Alnylam’s business. Prior to joining Alnylam, Tiffany held leadership roles at Millennium/Takeda Oncology, ARIAD, and Epizyme, all based in Cambridge, Massachusetts. Tiffany’s work in Patient Advocacy spans 12 years. As the Director of Medical Education at Millennium/Takeda, Tiffany helped launch bortezomib for Multiple Myeloma and Mantle Cell Lymphoma, and oversaw that organization’s educational grants, including educational grants to patient organizations around the globe. As the Head of US Medical Affairs at ARIAD, Tiffany helped launch ponatinib for Chronic Myeloid Leukemia, and was responsible for, among other things, establishing the global patient advocacy function. While at Epizyme, Tiffany established and grew the patient advocacy and engagement function, developed a granting and giving program, and led global outreach and engagement. When she’s not working, Tiffany enjoys reading, spending time with family and friends, and watching her son play hockey.
Ajanta Patel MD, MPH is Medical Director of Chronic Disease Prevention and Health Promotion at the Chicago Department of Public Health. In her role, she directs the Chronic Disease Division’s community outreach and linkages, health promotion programs, and data and surveillance insights and opportunities as they inform and improve the conditions and health determinants across Chicago. In her prior role as Assistant Professor at The University of Chicago, she worked as a Medical Director of Clinical Informatics and developed quality improvement programs and trainings. She is a clinically practicing Pediatric Pulmonologist at La Rabida Children’s Hospital in Chicago. Dr. Patel is board certified in Pediatric Pulmonology, Pediatrics, and Quality Improvement and earned her MD and MPH from Emory University; she is an alumna of Amherst College.
Brian currently serves as the CareFirst’s Vice President, Provider Collaboration and Network
Transformation. In this role, he is responsible for leading our overall provider and network-
related business functions, which includes the Practice Transformation Group, Provider
Contracting, Payment Model DesignNetwork Strategy, Network Operations, and Healthcare
Delivery Partner Relations. CareFirst’s is currently executing a 5-year transition from “Volume to
Value” in the company’s Medicare Advantage, Medicaid and commercial lines of business. He is
supported in this effort by a team of experts in value-based payment models, practice
transformation, data analytics, contracting strategies, and provider-relationship collaborators,
each dedicated to making healthcare more affordable, accessible, and equitable for the
communities CareFirst serves.
He gained experience in various areas of the health care sector for over 25 years, working in in
various management roles, ranging from small provider organizations, to start-ups, to a multi-
national Fortune 500 company.
Brian has served on several corporate, non-profit and community Boards of Directors over the
years and currently serves on the Boards of CRISP, the Prince George’s Chamber of Commerce,
and the CareFirst Associates’ Political Action Committee.
Mary Beth Terry, PhD is a Professor of Epidemiology at Columbia University’s Mailman School of Public Health. She is a cancer researcher with a primary focus on reducing the breast cancer burden. She leads the Chronic Disease Unit in the Department of Epidemiology and conducts research addressing the etiology, prevention, distribution, natural history, and treatment outcomes of chronic diseases including cancer and cardiovascular disease. For over 20 years, she has led studies in New York City and around the world focused on understanding the role of environmental modifiers of cancer risk. She currently co-leads multi-institutional efforts in New York City to reduce health disparities in multiple chronic diseases and to increase diversity in clinical trials. She also serves as Associate Director of Population Science and Community Outreach for the Columbia’s Herbert Irving Comprehensive Cancer Center. She teaches epidemiological methods and data science to public health students, medical students and undergraduate students. Dr. Terry serves on the Board of Scientific Counselors and the PDQ Genetics Board for the National Cancer Institute.
Kenneth Snow is Product Strategy Medical Director in the Pharmacy Services Section of CVS Health. His focus is on the advancement of the CVS Health clinical strategy to improve the health of our customers and the quality of care they receive. He also serves as Medical Director for Clinical Trial Services overseeing projects for external clients with attention to analytical results and clinical conclusions.
Dr. Snow serves as lead for the endocrinology and gastroenterology condition analysis team and as a thought leader around diabetes care and chronic disease management.
Previously, Dr. Snow served as a medical director for care management in New England.
Prior to joining Aetna in January of 2014, Dr. Snow was Chief Medical Officer for NeuroMetrix, a medical device company involved in the diagnosis and treatment of diabetic neuropathy. Previously, Dr. Snow was on the staff of the Joslin Diabetes Center in Boston for 19 years including 5 years as Chief of the Adult Diabetes Section. In addition, he was an Assistant Professor of Clinical Medicine at Harvard Medical School.
Dr. Snow attended MIT and Johns Hopkins School of Medicine. He did his internship and residency in Internal Medicine at Northwestern Memorial Hospitals in Chicago and his fellowship in Endocrinology at the New England Medical Center Hospitals in Boston. He received his MBA from the University of Massachusetts.
Michael McKnight is GHHI’s Senior Vice President of National Programs, heading up advocacy, policy analysis, and work on innovative financing and partnerships. He leads projects around the country that are collaborations that include healthy homes and energy efficiency providers, healthcare payers, and healthcare providers, utilizing the impact that housing has on health outcomes as a new funding source for home repair services. He has focused on reimbursement for healthy homes interventions from Medicaid and other healthcare payers and the return on investment of education and environmental control in combatting asthma and home-based injuries. He also takes the lessons learned on the ground and formulates policy recommendations or identifies best practices to take to scale. His portfolio includes over thirty projects advancing innovative partnerships with housing and healthcare entities, including some of the first housing programs to be directly funded by a Medicaid managed care organization.
Amy Neftzger has worked in healthcare analytics for over two decades. As an applied researcher, her focus in on utilizing data science to improve operational processes and healthcare outcomes. Her experience includes working for vendors, Medicare approved contractors (MACs), and health plans, as well a serving on industry committees and special workgroups for The Disease Management Association of America, URAC, The Gallup Well-Being Index, and DaVinci FHIR (HL7). She currently works for United Healthcare as Senior Director, Advanced Research and Analytics managing analytic teams in support of high risk member operations.
Dr. Kyu (“Q”) Rhee serves as Senior Vice President and Chief Medical Officer of Aetna at CVS Health. He and his team lead the integration and delivery of clinical and population health solutions. He is passionate and grateful to work for a health care innovation company with a simple and clear purpose: “to help people on their path to better health” from the community to the home to the palm of their hand.
Dr. Rhee is a practicing physician in both internal medicine and pediatrics. Prior to joining CVS Health, Dr. Rhee was the Chief Health Officer of IBM where he and his team had global responsibility for IBM’s efforts to transform health through the use of data, analytics, artificial intelligence, and services. Before that, he was the Chief Public Health Officer at the Health Resources and Services Administration (HRSA), which is the primary federal agency for improving access to health care services for people who are uninsured, isolated, or medically vulnerable. Prior to his public service, he worked as a National Health Service Corps primary care physician and Chief Medical Officer in community health settings in Washington, DC and Baltimore. During that time, he taught at the George Washington University School of Public Health, where he was awarded for his classes in Community Health Leadership and Health Disparities.
Maureen Pike is the Director of Social and Clinical Care Integration for Trinity Health, a multi-institutional Catholic health care delivery system spanning 25 states. In this role, she collaborates with leadership across clinical, business, and community health domains to sustainably improve the health and well-being of the most vulnerable patient populations. This work includes scaling social needs screening, bidirectional patient referrals to community-based social resources, health behavior change programming, Community Health Worker integration, equitable primary care delivery for the underserved, and collaborative management of dual-eligible ACO patients.
She previously served as the Regional Executive Director of Community Health and Well-Being for Loyola Medicine, a Trinity Health member health system outside of Chicago, IL, where she led a team in applying public health tools and methodologies to strengthen health system impact in the community. Her prior experience includes critical care nursing in Akron, OH and Seattle, WA; leading an FQHC-based health care access and health coaching program for the uninsured in Howard County, MD that received a 2010 U.S. DHHS Healthy Living Innovation Award; and national scaling of evidence-based chronic disease prevention and management programs and community-clinical partnership development at the YMCA of the USA, the Y’s national resource office.
Maureen earned a Bachelor of Science in Nursing from Kent State University, Master of Public Health from the Johns Hopkins Bloomberg School of Public Health, and Master of Business Administration from Northwestern University’s Kellogg School of Management where she received a Drake Scholarship Award for Women in Leadership.
Tricia Mullins is the Global Head, Early Patient Engagement & Professional Societies (Ex-China) at BeiGene. Tricia has over 20 years of experience working in patient advocacy, medical affairs, and commercial operations globally, specializing in ultra-rare diseases, oncology, and conditions critical to public health priorities. She has held key leadership roles of increasing responsibility over her career and is a strong advocate of the importance of the patient’s voice. Tricia is passionate about patients, advocacy, and access, bringing new innovative solutions to companies, patient organizations, patients and their families living with rare, chronic, and life-threatening conditions. Tricia holds a Bachelor of Science degree from St. John’s University and is pursuing her Master’s in Public Health.
In her spare time, Tricia serves as Co-Chair, Board of Directors at the Neuromuscular Disease Foundation (NDF), a non-profit organization, for those living with GNE Myopathy, an ultra-rare condition. Tricia also serves as an ongoing mentor to numerous advocates in the rare disease community.
Glen is a veteran of the healthcare industry, having led health plan, provider and health services businesses in both public and privately funded environments. Glen has managed several successful turn-arounds and is experienced leading high growth companies in rapidly evolving sectors.
Before starting at Upward Health, he served as CEO and Board Member of ArroHealth, Inc., a top provider of risk adjustment services and population health analytics. Under his leadership, ArroHealth became one of the fastest growing healthcare companies in the nation. Prior to ArroHealth, Glen served as Medicare CEO at Centene Corporation, leading a national book of business focused primarily on dual eligibles. Before Centene, he was President of Fidelis SecureCare, a VC-backed Medicare Institutional Special Needs plan providing insurance plans for enrollees with multiple chronic diseases. Glen also was COO at the Express Scripts Insurance Company, where he led the company’s Medicare program and launched its national Prescription Drug Plan, now a multi-billion-dollar business and the largest in the country. He started his career at Oxford Health Plans.
Glen earned a B.A. in Economics and English from Boston College and an M.B.A. from Harvard Business School. He serves on the Board of Directors of Nuvem Health and volunteers at several local and international charities, including as Chairman of Shoulder to Shoulder.
Kristin Wikelius is the Chief Program Officer at United State of Care. In this capacity, she leads the organization’s programmatic work to develop and advance innovative solutions to build a more affordable and equitable health care system.
Kristin brings deep experience in the health policy sector. Before joining USofCare, she served in the Office of Legislation at the Centers for Medicare & Medicaid Services (CMS), where she worked on issues related to Medicare, Medicaid and private insurance. Prior to her service at CMS, Kristin worked on Capitol Hill for nearly a decade providing counsel to members of Congress, including Sen. Dianne Feinstein (D-CA). Kristin holds a BA from Williams College and a Masters in Public Affairs (MPA) from the School of Public and International Affairs at Princeton University.
Richard Freeman Jr., M.D., MHL, is chief Medical Officer of St. Elizabeth’s Medical Center (SEMC). Dr. Freeman previously held multiple positions at Dell Medical School at the University of Texas at Austin, where he most recently served as Senior Executive for Special Initiatives. Dr Freeman is a physician-executive with deep experience in strategic design, leadership development, practice management, budget creation and execution, clinical and academic program development, talent acquisition, and research. He has demonstrated success in complex, regionally dispersed, reform-driven, academic health systems. He brings a global perspective and an entrepreneurial collaborative approach to building, measuring, and advancing team-based programs to enhance value across the clinical and academic healthcare spectrum.
Milagros Abreu is the Executive Director, President & Founder of the Latino Health Insurance Program. Milagros has a demonstrated history of working in public health, wellness and community based organizations. She is skilled in Nonprofit Organizations, Nonprofit Management, Program Evaluation, Case Management, and Volunteer Management. She is a strong business development professional with a Doctor in Medicine and public health focused in access to medical care, preventive Medicine and epidemiology from Boston University and the University Autonoma of Santo Domingo.
Lorraine Stiehl was named CEO of the American Liver Foundation in January 2021. A successful non-profit leader for over three decades, Lorraine supports patients battling chronic diseases and advocates for disease prevention efforts. Appointed by the U.S. Secretary of Health and Human Services (HHS), Lorraine served on the National Institute for Diabetes and Digestive and Kidney Diseases (NIDDK) Advisory Board at the National Institutes of Health (NIH).
Lorraine has worked for numerous chronic health causes including liver disease, diabetes, and cancer – and she has been a passionate advocate for organ transplantation and stem cell research. She also worked for nearly two decades at the University of California San Francisco (UCSF), providing leadership in clinical trial education and recruitment. In 2017, Lorraine co-authored a book, “What To Do When Your Partner Has Diabetes: A Survival Guide.”
As a lifelong caregiver, Lorraine knows first-hand how chronic disease impacts families. Her husband has lived with a challenging autoimmune disease for more than 60 years and an organ transplant for 14 years. Highly motivated to support non-profit organizations focused on delivering life-saving programs and research, Lorraine has raised millions of charitable dollars including funds generated through major gifts, events, research grants, and public awareness campaigns.
Tanya Dwyer is the Director of Chronic Disease Programs of Commonwealth Care Alliance(CCA) Health Plan. Her 20+ years of clinical experience in management of chronic heart failure as a registered nurse and advanced practice clinician lead her to creating integrated care models to systematically transform how clinician’s approach chronic disease management in practice.
To promote the health and well being of dually eligible and Medicare advantage health plan enrollees at CCA these evidence -based care models and approaches are integrated into the care delivery model to support health plan members to share in their chronic disease journey with their providers.
Natasha Davis, MBA, is the Director of Chronic Disease Prevention & Health Promotion at the Visiting Nurse Association Health Group.
Their interests are to promote public health and wellness initiatives nationally and to engage stakeholders and community members in discussions about factors that drive disparities in health and health care and ultimately empower individuals to create change to obtain health equity.
Nalini Saligram, Ph.D, is the Founder & CEO of Arogya World, a global health non-profit committed to changing the course of chronic disease. She is an Ashoka Fellow.
Under Nalini’s leadership, Arogya World designs and implements scalable, science-based diabetes prevention programs in Indian schools, workplaces, and the community. As a tireless advocate for NCD prevention, Nalini leverages public-private partnerships and global platforms to improve the world we live in. Arogya World has made three Clinton Global Initiative Commitments (one in 2011, and two in 2013), a United Nations Every Woman Every Child Commitment (2014), was active with MIT’s SOLVE effort (2017), and was named a finalist for the Peter F. Drucker Award for Nonprofit Innovation (2014). Her story and that of Arogya World has also been highlighted in a book – The Healthcare Gamechangers. In 2021, on her watch, Arogya World was chosen to be part of the Google AI for Social Good effort.
Nalini has lived and worked in many parts of the world, including Merck in Philadelphia, Merial in Atlanta, Glaxo Wellcome in London, and Hill & Knowlton in Hong Kong.
Nalini has a Ph.D. in biochemistry from the Indian Institute of Science, Bangalore. She serves on the Dean’s Council at the Rollins School of Public Health at Emory University and is active with the Taskforce on Women & NCDs, Indiaspora, the India Philanthropy Alliance, Foresight Global Health and the Global Centre for Healthy Workplaces. She is based in Atlanta.
Elizabeth Montgomery is the Vice President of Learning Strategies and Primary Care Programs at the National Kidney Foundation. Ms. Montgomery joined the organization specifically to advance CKDintercept, a multi-pronged strategy to improve chronic kidney disease integration into population health strategies in primary care. As part of these efforts, Ms. Montgomery led the development of the NKF CKD Change Package collaborating with the Million Hearts Campaign to include CKD interventions in their Hypertension materials. She spearheaded the NKF Laboratory Engagement Initiative, an ongoing collaboration among the nation’s leading pathology societies and laboratories to streamline CKD testing in primary care and ensure that race-free testing approaches are employed in kidney disease. Ms. Montgomery also led the development efforts for the MIPS and HEDIS measures advanced by NKF. She is the architect of the NKF data strategy engaging payers and large health systems in an evaluation of their data to identify and engage people with undiagnosed chronic kidney disease resulting in the implementation of community-based CKD programs in several states. Ms. Montgomery works with payers and integrated health networks on the development of their internal kidney disease strategies. She also leads the NKF collaborations with the Virginia Department of Health and the Missouri Department of Health and Senior Services which have resulted in increased CKD testing and recognition in community clinic settings. Ms. Montgomery also leads the team responsible for the development of the NKF educational materials. In this capacity, she has led the creation of several novel approaches to engaging and educating people living with kidney disease.
In 2005, Craig joined UnitedHealthcare to begin forming a team of strategic customer analytic specialists. That team is focused on leveraging clinical, financial and consumer behavior healthcare data in a strategic customer dialog. Their goal is to partner with employers, helping them to maintain healthcare affordability and increase their competitive advantage with a healthy and productive workforce.
Craig served many customers himself and many more through his team. He was also accountable for the continual innovation of analytic tools nationally, supporting commercial, public sector and government programs. Those innovations focused on the ability to hot spot subsets of the population to focus on the communities in need of interventions.
Starting in 2013, Craig assumed the role of Senior Vice President of Analytic Innovations for UnitedHealth Group. In this role, he focused on analytic innovations, community health analytics and complex customer support for UHG. He leveraged the breadth of UHG’s data to create actionable insights across a wide array of audiences ranging from customers to communities to policy makers. He focused on spreading best practice innovations across the UHG enterprise to impact all of the members that it serves. Craig also served as an Innovation Champion for the enterprise.
Beginning in 2016, Craig transitioned into UnitedHealthcare to focus on enhancing the role that analytics plays in our ability to support our National Account customers. Craig formed the Center for Advanced Analytics to focus on analytic innovations that change the way we evaluate health care value. His team also focuses on the largest most complex clients that require a deeper and broader view of data, ranging from cost and utilization data to productivity and disability exposure. He is constantly working on inventing the next generation of healthcare analytics.
Amy Shannon serves as the Director of Social Determinants of Health (SDoH) Programs and Products for Highmark Health. Amy has over two decades of experience within the healthcare industry. As a licensed social worker, she is passionate about designing and implementing programs that support every member’s whole health – physical, social, and mental health. Throughout her tenure at Highmark, she has supported the development of community-based programming for at risk populations, virtual wellness programming, design and implementation of social needs assessments and the program delivery for member interventions
The time has come to meet in-person once again! Join your peers for live presentations, engaging discussions and face-to-face networking. Catch up with familiar faces and make new connections within the field.
We will be coming together in Boston, MA.
Our venue will be announced soon!
Partner With Us
Bringing together senior-level executives from across the industry, the inaugural Future of Chronic Disease summit promises an unrivalled networking and learning opportunity for everyone working in this space.
Future of Chronic Disease provides a rare opportunity to showcase your offering to a dedicated, world-class audience. Spaces are limited this year!
Please contact our Commercial Manager Iain (firstname.lastname@example.org), to discuss opportunities for involvement.
Register for the Event
For pricing and booking options please click the button to go to the registration page.